Stunting growth: association of the blood pressure levels and ACE activity in early childhood.
Angiotensin converting enzyme (ACE) converts angiotensin I to angiotensin II and inactive bradykinin. Several studies carried out in our laboratory have consistently identified three isoforms of ACE, at 65, 90 and 190 kDa, with the 90-kDa isoform being a possible genetic marker of hypertension. Based on these observations and the fact that nutritional stunting can be associated with hypertension, we have investigated the expression and activity of ACE in stunted children and its association with blood pressure (BP) levels and nutritional state. Sixty children aged 2-7 years were selected for this study. A urine sample was collected from each child. Angiotensin converting enzyme activity was evaluated using two different substrates, and ACE expression was detected by Western blotting. Our results show that nutritional stunting is associated with high ACE activity in childhood and that adjustment by gender does not modify the strength of this association. A greater percentage of stunted children had increased BP levels, and this clinical parameter was inversely correlated with anthropometric indicators. A greater urinary protein expression of the three ACE isoforms was observed in the group of children with growth stunting. Our findings suggest that the reported high risk of hypertension in stunted adolescents and adults are, at least partly, associated with abnormalities in the renin-angiotensin system.
Febba
Andréia
A
Division of Nephrology, Federal University of São Paulo, R. Botucatu, 740, São Paulo, SP, Brazil, 04023-900.
Sesso
Ricardo
R
Barreto
Gênia Pithon
GP
Liboni
Claudia Silva
CS
Franco
Maria C P
MC
Casarini
Dulce Elena
DE
D001794:Blood Pressure / Q000502:physiology; D002648:Child; D002675:Child, Preschool; D004789:Enzyme Activation; D005260:Female; D006130:Growth Disorders / Q000453:epidemiology* / Q000378:metabolism*; D006801:Humans; D006977:Hypertension, Renal / Q000453:epidemiology* / Q000378:metabolism*; D015151:Immunoblotting; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000652:urine*; D012307:Risk Factors
D007703:Peptidyl-Dipeptidase A
Mol Biotechnol. 2003 May;24(1):27-39
12721494
Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76
15286277
Pediatr Transplant. 2005 Oct;9(5):612-7
16176418
Hypertension. 2007 Aug;50(2):396-402
17576855
Hypertension. 2003 Oct;42(4):693-701
12900433
Clin Sci (Lond). 2008 Mar;114(5):375-80
17953515
Br J Nutr. 2006 May;95(5):996-1001
16611392
J Nutr. 1998 Feb;128(2 Suppl):415S-420S
9478039
Diabetes. 1998 Mar;47(3):470-5
9519756
Pediatr Nephrol. 2003 May;18(5):435-9
12736805
Metabolism. 2003 Aug;52(8):1005-11
12898465
Nephron Clin Pract. 2004;97(2):c61-6
15218331
Hypertension. 1995 Dec;26(6 Pt 2):1145-8
7498985
J Nutr. 2000 Oct;130(10):2520-6
11015484
Am J Med. 1976 May 31;60(6):749-59
190881
Am J Clin Pathol. 1976 Aug;66(2):416-24
181981
J Pediatr (Rio J). 1999 Jul-Aug;75(4):256-66
14685527
Pediatrics. 1989 Oct;84(4):633-41
2780125
Proc Natl Acad Sci U S A. 1988 Dec;85(24):9386-90
2849100
Hypertension. 2005 Nov;46(5):1169-74
16203874
Eur J Pediatr. 1990 Nov;150(1):19-21
1964119
Life Sci. 2007 Jan 30;80(8):782-7
17161436
Diabetes Care. 2003 Feb;26(2):274-8
12547848
Nature. 1970 Aug 15;227(5259):680-5
5432063
Diabet Med. 2001 Aug;18(8):646-53
11553202
Life Sci. 1997;60(15):1213-21
9096238
Ann Intern Med. 1999 Feb 16;130(4 Pt 1):322-4
10068392
J Cell Physiol. 2003 Jul;196(1):171-9
12767053
Am J Hypertens. 1995 Jul;8(7):657-65
7546488
Clin Sci (Lond). 1998 Apr;94(4):373-81
9640343
Nutr Metab Cardiovasc Dis. 2004 Feb;14(1):26-33
15053161
Kidney Blood Press Res. 2006;29(2):108-25
16837795
Int J Biochem Cell Biol. 2001 Jan;33(1):75-85
11167134